Table 1 Demographics and clinical characteristics of the study population
Study population (N = 371) | |
|---|---|
Demographics | |
Age at admission, years | |
Mean (SD) | 55.0 (9.4) |
Median (IQR) | 57.0 (50.0–61.0) |
Sex, female | 104 (28.0) |
BMI at admission, kg/m2a | |
Mean (SD) | 29.5 (5.3) |
Median (IQR) | 28.4 (25.8–32.2) |
Migration background | |
European | 258 (69.5) |
Dutch Caribbean | 56 (15.1) |
Asian | 24 (6.5) |
Turkish | 17 (4.6) |
(North) African | 16 (1.3) |
Educational level | |
Low | 106 (28.6) |
Middle | 137 (36.9) |
High | 128 (34.5) |
Clinical characteristics | |
Comorbidities | |
≥ 1 | 295 (79.5) |
Obesity (BMI ≥ 30) | 160 (43.1) |
Cardiovascular disease | 122 (32.9) |
Pulmonary disease | 81 (21.8) |
Diabetes | 71 (19.1) |
Autoimmune and/or inflammatory disease | 33 (8.9) |
Malignancy | 29 (7.8) |
Neurological disease | 28 (7.5) |
Renal disease | 25 (6.7) |
Gastrointestinal disease | 23 (6.2) |
Mental disorder | 16 (4.3) |
Treatment a | |
No treatment | 86 (23.2) |
Steroids | 259 (69.8) |
Antivirals | 54 (14.6) |
Anti-inflammatory | 50 (13.5) |
(Hydroxy)chloroquine | 9 (2.4) |
Convalescent plasma | 3 (0.8) |
LOS hospital, days | |
Mean (SD) | 19.7 (20.0) |
Median (IQR) | 11.0 (6.0–29.0) |
ICU admission | 161 (43.4) |
LOS ICU, days a | |
Mean (SD) | 21.8 (16.3) |
Median (IQR) | 18.0 (9.0–31.0) |
Oxygen supplementation | 362 (97.6) |
High flow nasal cannula a | 122 (34.9) |
Invasive mechanical ventilation | 136 (36.7) |
Length of intubation, days a | |
Mean (SD) | 20.3 (13.9) |
Median (IQR) | 16.0 (9.0–29.8) |
Tracheostomy a | 56 (15.3) |
Time interval between hospital discharge and follow-up visit | |
3 months visit, days, mean (SD) | 95.5 (13.9) |
6 months visit, days, mean (SD) | 187.0 (15.1) |
12 months visit, days, mean (SD) | 368.8 (14.7) |